Analyst Price Targets — HCA
Latest News for HCA
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially supporting long-term profitability and EBITDA growth.
On August 25, 2026, we conducted a DCF analysis for HCA Healthcare Inc (HCA), a company that has shown varied price performance recently. The stock has experien
Bank of Nova Scotia acquired a new position in shares of HCA Healthcare, Inc. (NYSE: HCA) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 47,381 shares of the company's stock, valued at approximately $18,473,000. Other institutional investors have also modified their holdings of
B. Metzler seel. Sohn and Co. AG bought a new position in HCA Healthcare, Inc. (NYSE: HCA) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,563 shares of the company's stock, valued at approximately $4,118,000. Other hedge funds also recently bought
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.